+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

LG's OLED display becomes the first to receive an eye protection certification

Jan 5, 2021, 11:21 IST
IANS
TOI
Seoul, LG Display, the world's leading large size OLED panel maker, said on Tuesday that its organic light-emitting diode (OLED) TV panel has received an eye protection certification for low blue light emission.
Advertisement

Its OLED display became the industry's first TV panel to win an accreditation from Eyesafe, a U.S.-based eye protection certification agency, according to LG Display.

Eyesafe developed standards for eye protection in cooperation with TUV Rheinland AG, a German technical test service and certification organisation.

It measures blue light, which can cause sore eyes and even sleep disorders when people are excessively exposed to it, reports Yonhap news agency.

The certification requirements state that the proportion of harmful blue light out of a product's total blue light emissions must be less than 50 per cent.

Advertisement

LG Display said its 65-inch OLED TV panel meets the standards with the portion of harmful blue light standing at only 34 percent, the lowest among TV panels and about half of that of liquid crystal display (LCD) TV panels.

Unlike LCD, OLED does not require a backlight unit since it uses self-lighting pixels.

LG Display said it plans to showcase OLED display solutions that highlight protection to users' eyes and health at the Consumer Electronics Show (CES) 2021 that will be held online next week.


SEE ALSO:
Top stocks to watch — HDFC, Tech Mahindra, L&T, Bajaj Finance, IIFL Securities, Sun Pharma, and others
Tatas got AirAsia stake at a 20% discount while IndiGo and SpiceJet’s value has doubled since pandemic broke out
Bharat Biotech sees rivals’ conspiracy in all the criticism for the approval for Covaxin
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article